About PAIGE
PAIGE is a company based in New York (United States) founded in 2018 by David Klimstra and Thomas Fuchs was acquired by Tempus in August 2025.. PAIGE has raised $241 million across 8 funding rounds from investors including Microsoft, Goldman Sachs and Tempus. PAIGE offers products and services including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba. PAIGE operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter New York, United States
- Founders David Klimstra, Thomas Fuchs
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Paige Ai, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PAIGE
PAIGE offers a comprehensive portfolio of products and services, including Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI for detecting and diagnosing prostate cancer on tissue images
AI applications for breast cancer identification and classification
AI tools for gastrointestinal cancer detection and classification
Multi-modal tool to streamline pathology workflows and diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of PAIGE
PAIGE has successfully raised a total of $241M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $19.5 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series C — $19.5M
-
First Round
First Round
(05 Feb 2018)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series C - PAIGE | Valuation | Microsoft |
|
| Mar, 2021 | Amount | Series C - PAIGE | Valuation | KKR , Casdin Capital | |
| Jan, 2021 | Amount | Series C - PAIGE | Valuation | Johnson & Johnson Innovation – JJDC , Casdin Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PAIGE
PAIGE has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, Goldman Sachs and Tempus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PAIGE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PAIGE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Paige Comparisons
Competitors of PAIGE
PAIGE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Paige
Frequently Asked Questions about PAIGE
When was PAIGE founded?
PAIGE was founded in 2018.
Where is PAIGE located?
PAIGE is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of PAIGE?
Razik Yousfi is the current CEO of PAIGE.
Is PAIGE a funded company?
PAIGE is a funded company, having raised a total of $241M across 8 funding rounds to date. The company's 1st funding round was a Series C of $100M, raised on Feb 05, 2018.
What does PAIGE do?
Founded in 2018 and based in New York, United States, the company operates in the healthcare technology sector, specializing in AI-driven computational pathology. Deep learning algorithms, utilizing convolutional and recurrent neural networks, are applied to analyze visual and clinical data for cancer diagnosis and treatment. Products such as FullFocus support pathology workflows, while PAIGE.AI aids in patient stratification and biomarker development for treatment planning.
Who are the top competitors of PAIGE?
PAIGE's top competitors include Aignostics, Deciphex and Pictor Labs.
What products or services does PAIGE offer?
PAIGE offers Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige Alba.
Who are PAIGE's investors?
PAIGE has 12 investors. Key investors include Microsoft, Goldman Sachs, Tempus, KKR, and Johnson & Johnson Innovation – JJDC.